retatrutide type 2 diabetes phase 2 trial hba1c Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Reta and Type 2 Diabetes

Protein Helps Protect Lean Mass During Weight Loss Protein matters even more when appetite is lower and total calories are down

Lost weight on 12mg weekly

Insights from genetic studies of metformin action in humans Recently, genome-wide association studies have been undertaken to assess genetic contributions to glycaemic responses to metformin

Although GLP-1 medications are often discussed in the context of weight management or blood sugar control, they actually work directly on the digestive system

Physiology (Bethesda)

The impact of glucagon-like peptide-1 receptor agonists on kidney outcomes: a meta-analysis of randomized placebo-controlled trials